1-3 of 3
E. Kubista
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hormonersatztherapie nach Mammakarzinom

Available to Purchase
Subject Area:
Oncology
E. Kubista
Journal: Onkologie
Onkologie (1997) 20 (6): 486–488.
https://doi.org/10.1159/000219013
Published Online: 13 May 2009
View article titled, Hormonersatztherapie nach Mammakarzinom
Open the PDF for Hormonersatztherapie nach Mammakarzinom in another window
Journal Articles

Der Einfluß von Hormonrezeptoren auf die Metastasenlokalisation beim Mammakarzinom

Available to Purchase
Subject Area:
Oncology
I. Stuller, C.C. Zielinski, P. Aiginger, P. Rausch, P. Pötzi, E. Kubista, H. Salzer, P. Sevelda, M. Langer, A. Staffen, J. Spona
Journal: Onkologie
Onkologie (1987) 10 (5): 302–303.
https://doi.org/10.1159/000216427
Published Online: 27 April 2009
View article titled, Der Einfluß von Hormonrezeptoren auf die Metastasenlokalisation beim Mammakarzinom
Open the PDF for Der Einfluß von Hormonrezeptoren auf die Metastasenlokalisation beim Mammakarzinom in another window
Journal Articles

Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients

Available to Purchase
Subject Area:
Oncology
F. Ploner, R. Jakesz, H. Hausmaninger, R. Kolb, M. Stierer, M. Fridrik, P. Steindorfer, M. Gnant, K. Haider, B. Mlineritsch, G. Tschurtschenthaler, G. Steger, M. Seifert, E. Kubista, H. Samonigg
Journal: Onkologie
Onkologie (2003) 26 (2): 115–119.
https://doi.org/10.1159/000069831
Published Online: 09 May 2003
View article titled, Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients
Open the PDF for Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients in another window